Asteroids: Astronomers find moon accompanying asteroid as it passed by Earth 
Asteroid: MIT scientists develop a device that simulates strikes 
Deep learning AI discovers surprising new antibiotics 
Microsoft Surface Book 3 with 32GB of RAM could be announced this Spring 
Pixelbook 2: Upgraded screen resolution and tablet-laptop form are some of the features 
‘Kingdom Hearts 3’ is not the end of the series, but it might be for Sora 
iPhone 12 Pro release date, specs: Apple’s flagships expected to arrive by September 
Sony Xperia 2 specs and features: Sony’s next flagship rumored to have same back camera package as the Samsung S20 
The ice melt in Antarctica 129,000 years ago caused a drastic increase in sea levels 
Aliens: Extra-terrestrial hunter organization makes their data available to the public 
GoPro HERO8 Black: Display Mod pre-order is expected to go live soon 
Online lectures mean fewer students are turning up – does it matter? 
Asteroids: Footage reveals a space rock seen exploding over England 
PS5 launch date uncertain as Sony pulls out from PAX East and GDC 2020 
‘World of Warcraft’: Feb. 19 hotfix addresses a bug preventing players from gaining mounts 
NASA: Agency announces its protocol in case of asteroid collision 
- News
- Economy
- Central Banks
- Investing
- Research
- Roundups
- Digital Currency
- Insights
- Technical Analysis
- Technology
- Business
- Law
- Health
- Nature
- Fintech
- Science
- Topic
- Opinions
- EconoTimes PRO
- ©Elmin Media . All Rights Reserved.
Automation Takes Over Stem Cell Manufacturing Too, FDA Approves
Stem Cell Illustration.PublicDomainPictures/Pixabay
When discussing stem cell research, most people would likely bring up scientists harvesting stem cells from living tissue. While this is certainly true, there is now a new method that would allow researchers to manufacture stem cells so that they have much more of it to work with. The U.S. Food and Drug Administration (FDA) recently approved the process employed by the Mayo Clinic, which actually automates the process.
In a press release, the Mayo Clinic describes both the process and implications of the FDA approval to stem cell research. Apparently, this allows the researchers to take the bone marrow of a donor and then produce a much higher quantity of stem cells that will then be used to advance research in regenerative medicine.
According to the medical director of Transfusion Medicine and the Human Cell Therapy Laboratory, Abba Zubair, this process is a huge boon for cases where the patient’s own stem cells are not enough to allow for treatment. These cases can often be a problem, mostly because harvesting stem cells is not exactly that easy.
“This may make treatments possible in cases where the patient’s own cells are not viable as therapy,” Dr. Zubair said. “In addition, because the cells can be produced in days instead of months, it may also make treatments available on short notice when they’re needed for acute care.”
As Futurism notes, stem cell research has already proven promising in a variety of treatment cases, addressing everything from arthritis to paralysis. By cranking up production of stem cells via an automated production method, not only will researchers have significantly more batches to work with, patients won’t have to wait for months to be treated.
On a side note, this process also highlights the huge advantages to automating the manufacturing process in the field of research and medicine. In these areas, robots are just taking over, and that might be for the best.
Editor's Picks
- Market Data
